MRI monitoring of focal cerebral ischemia in peroxisome proliferator-activated receptor (PPAR)-deficient mice

NMR in Biomedicine

Volumn 20, Issue 3, 2007, Pages 335-342

  Pialat, Jean Baptiste ^a,b   Cho, Tae Hee ^a,b   Beuf, Olivier ^c   Joye, Elisabeth ^d   Moucharaffie, Samir ^a,b   Langlois, Jean Baptiste ^e   Nemoz, Chantal ^b,c   Janier, Marc ^a,b,e   Berthezene, Yves ^a,b   Nighoghossian, Norbert ^a,b   Desvergne, Béatrice ^d   Wiart, Marlène ^a,f  

^a UNIVERSITÉ DE LYON   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e Small Animal Multimodal Imaging Facility   (France)

^f HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Brain; Focal ischemia; Inflammation; Knockout mouse; MRI; Peroxisome proliferator activated receptor (PPAR) ; PPAR

Indexed keywords

ANIMALS; BIOMEDICAL ENGINEERING; BRAIN; MEDICAL IMAGING; STATISTICAL METHODS;

FOCAL ISCHMIA; KNOCKOUT MOUSE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;

MAGNETIC RESONANCE IMAGING;

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENCEPHALITIS; GENOTYPE; IMAGE ANALYSIS; KNOCKOUT MOUSE; LINEAR SYSTEM; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; MOUSE STRAIN; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; STATISTICAL ANALYSIS; STRAIN DIFFERENCE; WILD TYPE;

MUS; MUS MUSCULUS;

EID: 34249724933     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1157     Document Type: Article

References (29)

1. Fisher M, Davalos A, Rogalewski A, Schneider A, Ringelstein EB, Schabitz W-R. Toward a multimodal neuroprotective treatment of stroke. Stroke 2006; 37(4): 1129-1136.
2. Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000; 405(6785): 421-424.
3. Youssef J, Badr M. Role of peroxisome proliferator-activated receptors in inflammation control. J Biomed Biotechnol 2004; 2004(3): 156-166.
4. Kostadinova R, Wahli W, Michalik L. PPARs in diseases: control mechanisms of inflammation. Curr Med Chem 2005; 12(25): 2995-3009.
5. Bordet R, Gele P, Duriez P, Fruchart JC. PPARs: a new target for neuroprotection. J Neurol Neurosurg Psychiatry 2006; 77(3): 285-287.
6. Cullingford TE, Bhakoo K, Peuchen S, Dolphin CT, Patel R, Clark JB. Distribution of mRNAs encoding the peroxisorne proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system. J Neurochem 1998; 70(4): 1366-1375.
7. Arsenijevic D, de Bilbao F, Plamondon J, Paradis E, Vallet P, Richard D, Langhans W, Giannakopoulos P. Increased infarct size and lack of hyperphagic response after focal cerebral ischemia in peroxisome proliferator-activated receptor beta-deficient mice. J Cereb Blood Flow Metab 2006; 26(3): 433-445.
8. Deplanque D, Gele P, Petrault O, Six I, Furman C, Bouly M, Nion S, Dupuis B, Leys D, Fruchart JC, Cecchelli R, Staels B, Duriez P, Bordet R. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenotibrate treatment. J Neurosci 2003; 23(15): 6264-6271.
9. Lee JH, Joe EH, Jou I. PPAR-alpha activators suppress STAT1 inflammatory signaling in lipopolysaccharide-activated rat glia. Neuroreport 2005; 16(8): 829-833.
10. Paumelle R, Blanquart C, Briand O, Barbier O, Duhem C, Woerly G, Percevault F, Fruchart JC, Dombrowicz D, Glineur C, Staels B. Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway. Circ Res 2006; 98(3): 361-369.
11. Xu J, Storer PD, Chavis JA, Racke MK, Drew PD. Agonists for the peroxisome proliferator-activated receptor-alpha and the retinoid X receptor inhibit inflammatory responses of microglia. J Neurosci Res 2005; 81(3): 403-411.
12. Benveniste H, Blackband SJ. Translational neuroscience and magnetic-resonance microscopy. Lancet Neurol 2006; 5(6): 536-544.
13. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 1995; 15(6): 3012-3022.
14. Nadra K, Anghel SI, Joye E, Tan NS, Basu-Modak S, Trono D, Wahli W, Desvergne B. Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta. Mol Cell Biol 2006; 26(8): 3266-3281.
15. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981; 1(1): 53-60.
16. GLM Repeated Measures Procedure, SPSS Advanced Models 11.0. SPSS Inc: Chicago, USA. 2001; 15-31.
17. Maeda K, Hata R, Hossmann KA. Differences in the cerebrovascular anatomy of C57black/6 and SV129 mice. Neuroreport 1998; 9(7): 1317-1319.
18. Dimagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22(9): 391-397.
19. Wiessner C, Allegrini PR, Ekatodramis D, Jewell UR, Stallmach T, Gassmann M. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab 2001; 21(7): 857-864.
20. Mori T, Town T, Kobayashi M, Tan J, Fujita SC, Asano T. Augmented delayed infarct expansion and reactive astrocytosis after permanent focal ischemia in apolipoprotein E4 knock-in mice. J Cereb Blood Flow Metab 2004; 24(6): 646-656.
21. Maeda K, Hata R, Hossmann KA. Regional metabolic disturbances and cerebrovascular anatomy after permanent middle cerebral artery occlusion in C57black/6 and SV129 mice. Neurobiol Dis 1999; 6(2): 101-108.
22. Barber PA, Hoyte L, Kirk D, Foniok T, Buchan A, Tuor U. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T. Neurosci Lett 2005; 388(1): 54-59.
23. Li F, Liu KF, Silva MD, Omae T, Sotak CH, Fenstermacher JD, Fisher M, Hsu CY, Lin W. Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats: correlation with histopathology. Stroke 2000; 31(4): 946-954.
24. Schroeter M, Franke C, Stoll G, Hoehn M. Dynamic changes of magnetic resonance imaging abnormalities in relation to inflammation and glial responses after photothrombotic cerebral infarction in the rat brain. Acta Neuropathol (Berl) 2001; 101(2): 114-122.
25. Hoehn M, Nicolay K, Franke C, van der Sanden B. Application of magnetic resonance to animal models of cerebral ischemia. J Magn Reson Imaging 2001; 14(5): 491-509.
26. Veltkamp R, Siebing DA, Sun L, Heiland S, Bieber K, Marti HH, Nagel S, Schwab S, Schwaninger M. Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Stroke 2005; 36(8): 1679-1683.
27. Zhang ZG, Zhang L, Ding G, Jiang Q, Zhang RL, Zhang X, Gan WB, Chopp M. A model of mini-embolic stroke offers measurements of the neurovascular unit response in the living mouse. Stroke 2005; 36(12): 2701-2704.
28. Saleh A, Wiedermann D, Schroeter M, Jonkmanns C, Jander S, Hoehn M. Central nervous system inflammatory response after cerebral infarction as detected by magnetic resonance imaging. NMR Biomed 2004; 17(4): 163-169.
29. Franklin K, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. Academic Press: San Diego, 1997.